Back to Report Store Home

Frontier Pharma: Orphan and Rare Dermatological Diseases – First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

  • Published: Sep-2018
  • Report Code: GBIHC483MR
  • Report Format: pdf

Description

List of Tables

Table 1: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 2: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 3: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 4: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 5: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 6: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 7: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 8: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 9: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 10: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 11: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 12: Pipeline Programs Targeting XXX

Table 13: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 14: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 15: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 16: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 17: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 18: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 19: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 20: Orphan and Rare Dermatological Disease, Global, Pipeline Programs Targeting XXX

Table 21: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 22: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

Table 23: Orphan and Rare Dermatological Diseases, Global, Key Features of XXX

Table 24: Orphan and Rare Dermatological Diseases, Global, Pipeline Programs Targeting XXX

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards